Case reports of latent HBV hepatitis in patients after neurosurgical treatment for hypothalamic and pituitary tumors

Niizuma, Kuniyasu; Ogawa, Yoshikazu; Kogure, Takayuki; Tominaga, Teiji

doi:10.1186/s12879-020-04971-2

Cited by 4 publications

(4 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The course of the inactive HBsAg carrier stage is usually benign. However, this stage carries a 20–30% risk of spontaneous reactivation and liver cancer [ 6 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of Hepatitis B Infection Among Pregnant Women in Oman

Al-Ismaili

Al-Jardani

Al-Hinai

et al. 2022

J Epidemiol Glob Health

View full text Add to dashboard Cite

Objective The primary objective of our study was to estimate the prevalence of hepatitis B infection among pregnant women in Oman. The secondary objectives were to test for other hepatitis B virus (HBV) serological markers and to determine hepatitis B viral load. Methods In this cross-sectional study conducted from June 2019 to December 2020, we randomly selected 2210 Omani women who attended antenatal clinics across the country. Pregnant women were tested for HBV surface antigen (HBsAg) using a commercial enzyme immunoassay; those who tested positive were further analyzed for other HBV serological markers: HBV core total antibody (anti-HBc), HBV core antibody IgM (immunoglobulin M) (anti-HBc IgM), hepatitis B virus e antigen (HBeAg) and hepatitis B virus e antibody (anti-HBe). They were also tested for hepatitis B viral load. Results This study included 2210 women with a mean age of 39 years. Ninety-five percent of the women who were invited to participate consented and were included in the study. Thirty-three (1.49%) tested positive for HBsAg. All participants tested negative for HBeAg and anti-HBc IgM and positive for anti-HBc and anti-HBe, and 30 (90.9%) women had their hepatitis B viral load measured. Three (10.0%) had undetectable viral loads, 23 (76.7%) had low viral loads of < 2000 (IU/ml), 2 had moderate viral loads between 2000 and 200,000 (IU/ml) and one had a high viral load of 486,000 (IU/ml). Conclusion Our study shows that the HBV prevalence in pregnant women is 1.49%, which is lower than what was reported earlier. Nevertheless, antenatal screening is still warranted, as there are vital interventions for the newborn and the mother.

show abstract

“…The course of the inactive HBsAg carrier stage is usually benign. However, this stage carries a 20–30% risk of spontaneous reactivation and liver cancer [ 6 ].…”

Section: Discussionmentioning

confidence: 99%

“…The virus genotype and the viral DNA in blood, as well as some patient factors (age, sex, genetic factors, immune status), seem to determine who will develop these outcomes. The prognosis of chronic hepatitis B infection depends on the severity of liver injury [ 6 ].…”

Section: Introductionmentioning

confidence: 99%

Prevalence of Hepatitis B Infection Among Pregnant Women in Oman

Al-Ismaili

Al-Jardani

Al-Hinai

et al. 2022

J Epidemiol Glob Health

View full text Add to dashboard Cite

show abstract

“…The World Health Organisation (WHO) has described the Hepatitis B classification as a major health challenge that causes a chronic infection exposing people to a high risk of deaths as a result of cirrhosis and liver cancer (WHO, 2016b). Globally, although 2 billion people retrospectively have traces of HBV infection, an estimated 257 million people are noted to be living with the chronic type (Niizuma et al, 2020;WHO, 2017b). Approximately, 887,000 deaths were reported to have resulted from HBV in the year 2015 (Hyun et al, 2019).…”

Section: Introductionmentioning

confidence: 99%

Assessment of health communication practice on hepatitis B in Southwest Nigeria

Adesina

Oyero

Okorie

et al. 2020

Cogent Social Sciences

View full text Add to dashboard Cite

In line with the Sustainable Development Goal 3:3 of ending the epidemic of hepatitis by year 2030, there is a global call for strategic information to understand viral hepatitis. Existing studies on hepatitis B virus (HBV) in Nigeria have primarily focused on health practitioners and their patients, to the neglect of detailed empirical data on health communication practice, especially as it relates to semi-urban and urban demographic information. The study set to find out the communication strategies employed by government and non-government organisations working on HBV, as well as the preferred health communication channels for hepatitis B by semi-urban and urban residents. The study adopted a mixed method. The qualitative method assessed the communication strategies employed by government and non-government health-related agencies in informing people on HBV in Nigeria while, the survey examined the preferred health communication channels for HBV management among 582 semi-urban and urban residents in Lagos, Oyo, and Ogun States, Southwest Nigeria. Bivariate analyses were performed on demographic variables and preferred health communication channels for HBV by states. This study found that government agencies and non-government organisations working on hepatitis B predominantly make use of interpersonal communication in getting the people informed of HBV. Also, residents of Southwest Nigeria (elderly, Evaristus Adesina ABOUT THE AUTHOR Adesina, Evaristus is a Researcher and a Lecturer of Mass Communication in Covenant University with high enthusiasm for identifying social problems and proffering solutions through positional and empirical research. Evaristus obtained his Bachelor of Science and Masters Degrees from Bowen University and the University of Lagos, respectively. He recently bagged his Ph.D. from

show abstract

“…Globally distributed herpesviruses and hepatitis viruses are of greatest concern because of the burden of disease and death they cause and the potential for outbreaks and epidemics [34,35]. These viruses have a latent form in their infectious cycle [36,37] that is resistant to known therapeutic agents. Moreover, latent human or animal viruses can contribute significantly to graft rejection in transplantation [38] or xenotransplantation [39].…”

mentioning

confidence: 99%